A brain mapping study funded by the NIH reveals which cell types may be the first to be affected. New research funded by the ...

The damage caused by Alzheimer's disease begins long before any symptoms show up. Over the course of years or decades in this preclinical stage ... especially late in the day (known as "sundowning").

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked.Among a ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

Memory loss presented early and was experienced 12 years before the clinically defined diagnosis of late-stage Alzheimer’s. The researchers concluded that "the findings of this review suggest ...

Feeling lonely increased risk for all-cause dementia by 31 percent and cognitive impairment by 15 percent. Loneliness is a ...

Higher Levels of Leptin Indicate Brain Protection Against Late-Life Dementia Sep. 18 ... the cellular changes that occur in Alzheimer's early stages, revealing potential new targets and routes ...

By comparing participants' first and second sleep studies, researchers discovered a link between each percentage point ...

November is Alzheimer’s Awareness Month, a time to heighten awareness about Alzheimer’s disease and show support for the more ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...